New York Life Investment Management’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
VCM
DAM
VPM
New York Life Investment Management's CL Position: Q1 2026 in Review
New York Life Investment Management increased its Colgate-Palmolive (CL) stake by 11% in Q1 2026, buying an estimated $1.18M and bringing the position to 133,748 shares worth $11.4M. The position accounts for 0.1% of the portfolio, ranked #184.
New York Life Investment Management first reported a position in CL in Q2 2013 and has held it in 26 quarters since. The position peaked at $12.7M in Q3 2024. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- New York Life Investment Management held 133,748 shares of Colgate-Palmolive worth $11.4M as of Q1 2026.
- New York Life Investment Management bought 13,220 Colgate-Palmolive shares in Q1 2026, an estimated $1.18M.
- Colgate-Palmolive made up 0.1% of New York Life Investment Management's portfolio in Q1 2026, its #184 holding.
- New York Life Investment Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 26 quarters since.
- New York Life Investment Management's Colgate-Palmolive position peaked at $12.7M in Q3 2024.
- 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.